The report " Global Muscle Hypertonia Treatment Market, By Drug Type (Baclofen, Diazepam, and Dantrolene), By Prognosis (Mild Condition, Moderate Condition, and Severe Condition), and Region - Global Forecast to 2029" Global muscle hypertonia treatment market is projected to grow from US$ XX billion in 2019 to US$ XX billion by 2029. Rising awareness about the muscle hypertonia treatment in the health care industry is the major factor driving the growth of the global muscle hypertonia treatment market. In addition to this, government investments in research in muscle hypertonia are also propelling the growth of the target market. Also, rising per capita income and changing lifestyle in emerging countries like India and China are expected to boost the growth of the muscle hypertonia treatment market in the forecast period. Moreover, launch of novel therapeutics for the treatment of hypertonia is also fuelling the target market growth. However, lack of awareness about the disease and its treatment among individuals is the major factor restraining growth of the global market.

Key Highlights:

• In feb 2019, Ipsen stated that it would acquire clementia pharmaceuticals to significantly boost rare disease portfolio

Key Market Insights from the report:          

The global muscle hypertonia treatment market accounted for US$ XX billion in 2019 and is projected to register a moderate CAGR of XX% over the forecast period. The market report has been segmented on the basis of drug type, prognosis, and region.

• By drug type, the global muscle hypertonia treatment market is segmented into into baclofen, diazepam, and dantrolene.
• By prognosis, the global muscle hypertonia treatment market is segmented into mild condition, moderate condition, and severe condition
• By region, North America dominates the global muscle hypertonia treatment market in terms of revenue due to increasing number of screening procedures, rising geriatric population, presence of leading manufacturers, increasing population, and technological advancements.

Browse 60 market data tables* and 35 figures* through 140 slides and in-depth TOC on " Global Muscle Hypertonia Treatment Market, By Drug Type (Baclofen, Diazepam, and Dantrolene), By Prognosis (Mild Condition, Moderate Condition, and Severe Condition), and by Region (North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa)- forecast till 2029

The prominent player operating in the global muscle hypertonia treatment market includes Codman & Shurtleff, Inc., Ipsen Inc., Medtronic, Inc., Orient Pharma Co., Ltd., IMed Pharmaceuticals, Taj Pharmaceuticals Limited, MediciNova, Inc., Sanofi Inc., and Genentech, Inc.